Síndrome de Dubin-Johnson
Peer reviewed by Dr Rachel Hudson, MRCGPLast updated by Dr Colin Tidy, MRCGPLast updated 15 Jun 2023
Satisface las necesidades del paciente directrices editoriales
- DescargarDescargar
- Compartir
Profesionales médicos
Los artículos de referencia profesional están diseñados para uso de los profesionales de la salud. Están escritos por médicos británicos y se basan en pruebas de investigación y directrices británicas y europeas. Puede que alguno de nuestros artículos sobre salud le resulte más útil.
En este artículo:
Synonyms: hyperbilirubinaemia II, DJS, Sprinz-Nelson syndrome
Seguir leyendo
What is Dubin-Johnson syndrome?1 2
Dubin-Johnson syndrome (DJS) is a rare benign chronic disorder of bilirubin metabolism, characterised by conjugated hyperbilirubinaemia, darkly pigmented liver and the presence of abnormal pigment in hepatic parenchymal cells.
DJS was first described in 1954 by Dubin et al and Sprinz et al who reported several cases of healthy young adults with chronic low-grade jaundice (mostly conjugated hyperbilirubinaemia) and black livers, with no other features of hepatobiliary disease.
It is an autosomal recessive disorder and genomic studies have shown that DJS results from homozygous or compound heterozygous mutations in ABCC2/MRP2 resulting in either absent or deficient expression of this transporter.
Several different mutations have been described in DJS patients, including exon skipping, missense, nonsense and base deletion. Most mutations result in stop codons and failure of MRP2 transcription.
There is no haemolysis and no elevation of other liver enzymes. There is impaired secretion of conjugated bilirubin and other non-bile salt organic anions from hepatocytes into the bile. It runs a generally benign course.
How common is Dubin-Johnson syndrome? (Epidemiology)
It occurs in about 1 in 1,300 people of Iranian ancestry with Jewish faith. However, it is very rare in those without such ancestry. It has also been reported in Japan. It is inherited as an autosomal recessive disorder and consanguinity is a risk factor.2
A seminal paper examined 101 cases in Israel from 1955 to 1969. Of the 101, there were 64 people of Iranian ancestry with Jewish faith and there was a 46% frequency of consanguineous marriage in the parents, compared with 26% amongst people of Iranian ancestry with Jewish faith generally.3
Seguir leyendo
Symptoms of Dubin-Johnson syndrome (presentation)1
DJS usually presents in young adulthood with predominantly conjugated hyperbilirubinaemia and otherwise normal liver studies. The conjugated hyperbilirubinaemia is mild because of urinary excretion of bilirubin glucuronides.
Most patients are asymptomatic except for occasional abdominal pain.
There is no risk of fibrosis or cirrhosis.
Rarely, DJS can present in the neonatal period:
Neonatal DJS differs from adult-onset DJS in that it presents with severe cholestasis and hepatomegaly.
Bilirubin levels can reach above 200 mg/L. Increased severity in neonates has been attributed to immature bile physiology combined with the MRP2 defect.
As the liver matures, infants become asymptomatic until later in life, when they can present with intermittent hyperbilirubinaemia.
Investigaciones1
Diagnosis is important to eliminate the possibility of other hepatobiliary disorders that may lead to hepatic injury.
FBC is usually normal as are LFTs with the exception of bilirubin which is elevated.4 A sulfobromophthalein test will show prolonged retention.
In addition to elevated conjugated bilirubin levels in the setting of normal liver function tests, urine tests are diagnostic:
Urine tests reveal normal total coproporphyrin levels but with 80% coproporphyrin I in affected individuals, compared to 75% coproporphyrin III in healthy controls.
Coproporphyrin I is a metabolic byproduct of heme synthesis and also an endogenous substrate of MRP2; therefore, serum and urinary levels are increased in the presence of defective MRP2.
Hepatobiliary iminodiacetic acid (HIDA) scan will show either normal or slightly delayed visualisation of the liver, with absent or delayed gallbladder filling.
Laparoscopy examination of the liver will show that it is dark in colour with deposition of a pigment that is rather like melanin.
Liver histology, though not necessary in establishing the diagnosis, characteristically shows the presence of dark lysosomal melanin-like pigment deposits.
Genotyping of ABCC2 gene is possible, but not usually part of the routine clinical work up.
Seguir leyendo
Diagnóstico diferencial
Another form of familial hyperbilirubinaemia is Rotor's syndrome but that shows no hyperpigmentation of the liver.2 The poor or absent imaging of the gallbladder may lead to an erroneous diagnosis of gallstones.
Hyperbilirubinaemia often indicates severe hepatobiliary disease of different causes.5 Primary biliary cirrhosis causes jaundice and hepatosplenomegaly but there is also marked pruritus and usually positive autoantibodies.
Management of Dubin-Johnson syndrome
DJS in a benign disease and in adolescents and adults it does not require treatment.
Reassurance is required that no treatment or further investigation is necessary once diagnosis is made. There is no reduction in life expectancy.1
Lecturas complementarias y referencias
- Hyperbilirubinemia, Rotor Type, HBLRR; Herencia mendeliana en el hombre en línea (OMIM)
- Dubin-Johnson Syndrome, DJS; Herencia mendeliana en el hombre en línea (OMIM)
- Memon N, Weinberger BI, Hegyi T, et al.Trastornos hereditarios del aclaramiento de bilirrubina. Pediatr Res. 2016 Mar;79(3):378-86. doi: 10.1038/pr.2015.247. Epub 2015 nov 23.
- Sticova E, Jirsa M; New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol. 2013 Oct 14;19(38):6398-6407.
- Dubin-Johnson Syndrome, DJS; Herencia mendeliana en el hombre en línea (OMIM)
- Giboney PT; Mildly elevated liver transaminase levels in the asymptomatic patient. Am Fam Physician. 2005 Mar 15;71(6):1105-10.
- Strassburg CP; Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):555-71.
Seguir leyendo
Historia del artículo
La información de esta página ha sido redactada y revisada por médicos cualificados.
Fecha de la próxima revisión: 12 de mayo de 2028
15 Jun 2023 | Última versión

Pregunte, comparta, conecte.
Explore debates, formule preguntas y comparta experiencias sobre cientos de temas de salud.

¿Se encuentra mal?
Evalúe sus síntomas en línea de forma gratuita